Pancreatitis during combination chemotherapy.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D008937:Mitomycins / Q000009:adverse effects; D010195:Pancreatitis / Q000139:chemically induced*; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D008937:Mitomycins; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate